Alzheimer’s at EMBO 2013: dietary treatment and prevention through autophagy

Here’s a PDF of my poster for the EMBO autophagy conference in May 2013.  And here’s the abstract.

Here’s the poster’s text:

An autophagic role in Alzheimer’s disease for intermittent dietary periods of very low-protein, high-carbohydrate intake

Hypothesis: Intermittent periods of very low-protein, high-carbohydrate dietary intake may enhance autolysosomal proteolysis in Alzheimer’s disease (AD) by increasing activity of transcription factor EB (TFEB).

Background: AD is characterized by 1) activation of neuronal autophagy with defective autolysosomal degradation,[1] and 2) neuronal insulin resistance, characterized by increased amyloid-β (Aβ) production in autophagosomes and reduced neuronal internalization of extracellular Aβ oligomers.[2]

Translocation of transcription factor EB (TFEB) from cytosol to nucleus increases transcription of 291 genes and thereby induces autophagy,[3] lysosomal biogenesis, acidification, and proteolysis.[4]

Phosphorylation of TFEB by mammalian target of rapamycin complex 1 (mTORC1) and by glycogen synthase kinase 3 (GSK3)[5] inhibits TFEB nuclear translocation.

GSK3 inhibition in transgenic AD mice increases acidification of lysosomes, reduces Aβ deposits, and ameliorates cognitive deficits.[6]

Why very low protein intake?  mTORC1 phosphorylation of TFEB is inhibited by amino acid starvation, even in the presence of strong insulin signaling.[7]  Very low protein intake, combined with GSK3 inhibition, is therefore expected to promote TFEB nuclear translocation.

Why high carbohydrate intake?  High carbohydrate intake stimulates secretion of insulin, which inhibits GSK3[8] and presumably therefore reduces GSK3’s phosphorylation of TFEB.  Combined with mTORC1 inhibition, enhanced insulin signaling should thereby promote TFEB nuclear translocation.

Continue reading

Protein restriction cycles reduce IGF-1 and phosphorylated Tau and improve behavior in Alzheimer’s mice

A recent University of Southern California study showed great benefit in cycling intake of dietary protein — well, not all protein, but essential amino acids — in mice with Alzheimer’s disease.

The protein restriction cycles improved memory and reduced brain levels of phosphorylated tau in the mice, but did not affect brain levels of β amyloid (Aβ) plaques.

The protein cycles lasted four months and consisted of alternating weeks of a normal diet and a protein-restricted (PR) diet.

The normal diet contained 25% protein, 17% fat, and 58% carbohydrate.

The PR diet lacked nine essential amino acids (EAA) – that is, amino acids the body cannot make: isoleucine, leucine, lysine, methionine, phenyalanine, threonine, tryptophan, valine, and arginine. Fat and carbohydrate contents were presumably the same as in the normal diet.

Interestingly, the researchers supplemented the PR diet by adding more of the remaining 11 amino acids, mainly the nonessential amino acids (NEAA), to make the diet’s nitrogen content the same as in the normal control diet. As a result, the PR diet contained about twice the amount of NEAA as did the normal diet.

Continue reading

An autophagic role in Alzheimer’s disease for intermittent dietary periods of very low-protein, high-carbohydrate intake

Here’s the text of an abstract I’ll be presenting at the European Molecular Biology Organization (EMBO) autophagy conference in Norway in May 2013:

….

Occasional periods of very low-protein, high-carbohydrate dietary intake may enhance lysosomal proteolysis in Alzheimer’s disease (AD) by increasing activity of transcription factor EB (TFEB) via inhibition of glycogen synthase kinase 3 (GSK3).

AD is characterized by 1) activation of neuronal autophagy with defective autolysosomal degradation, and 2) neuronal insulin resistance, characterized by increased amyloid-β (Aβ) production in autophagosomes and reduced neuronal internalization of extracellular Aβ oligomers.

Suitable AD therapies may therefore aim to reduce neuronal insulin resistance and increase activity of TFEB, a master gene regulator of lysosomal biogenesis. Upon cellular starvation and in response to inhibition of mammalian target of rapamycin (mTOR), TFEB translocates from the cytosol to the nucleus, whereupon it increases transcription of 291 genes, including many involved in autophagy. At least 20 of these genes participate in lysosomal biogenesis, acidification, and proteolysis.

Continue reading

Keep eating, say fat people’s brains

More on brain changes in obesity:

An April 2011 Nature article by French researchers demonstrated that diet-induced obesity in miniature pigs leads to decreased activation of the prefrontal cortex, a brain region used for “inhibition of inappropriate behavior, satiety, and meal termination.”  The brain activation was determined by regional blood flow as measured by SPECT imaging.

Like the pigs, obese men also show reduced activation of their prefrontal cortex, and it’s not known whether these brain changes cause obesity, or obesity causes the brain changes. Continue reading

Being fat suppresses brain cell formation

A new study from Harvard Medical School provides more evidence that diet-induced obesity hurts the hypothalamus, the brain region that drives your body’s energy usage and eating behavior.

As discussed here previously, a December 2011 University of Washington study showed that the hypothalamus in fat people is harmed by gliosis, a process leading to scarring.

This damage is possibly due to inflammation caused by eating a diet containing excess fat and/or energy (calories).  Rodents develop this brain damage after being fed a high-fat diet, so causation by diet appears certain, at least for mice and rats, if not humans. Continue reading

Brain damage in being fat

Unfortunately, many, if not all, obese people are brain damaged.

The damage, detectable by brain MRI, is subtle but potentially significant, like that done by punches to boxers’ heads.

University of Washington researchers revealed in a new paper, co-authored by Stephan Guyenet, that obesity in mice, rats, and humans is associated with, and may in at least some cases be caused by, inflammation and gliosis (scarring) in the brain region that controls eating and body weight, the hypothalamus. Continue reading